Single Ascending Dose Study of ANX105
Clinical trial NCT05288881 · COMPLETED
Trial details
- NCT number
- NCT05288881
- Sponsor
- Annexon, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2023-06-19
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.